 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 08/03/2026 |
$53.40 |
$53.98 |
$51.85 |
$53.66 |
433.70K | | 08/04/2026 |
$55.14 |
$55.48 |
$53.41 |
$55.13 |
417.60K | | 08/05/2026 |
$55.42 |
$56.65 |
$54.33 |
$54.99 |
316.60K | | 08/06/2026 |
$55.28 |
$56.07 |
$53.45 |
$54.77 |
288.80K | | 08/07/2026 |
$55.20 |
$57.38 |
$55.13 |
$56.61 |
546.70K |
 |
| AnaptysBio, Inc. is a clinical-stage biotechnology company focused on delivering immunology therapeutics. Co. is developing immune cell modulators, including two checkpoint agonists for autoimmune and inflammatory disease: rosnilimab, its PD-1 agonist, in a Phase 2b trial for the treatment of rheumatoid arthritis and in a Phase 2 trial for the treatment of ulcerative colitis; and ANB032, its BTLA agonist, in a Phase 2b trial for the treatment of atopic dermatitis. Co.'s preclinical immune cell modulator portfolio includes ANB033, an anti-CD122 antagonist antibody, and ANB101, a BDCA2 modulator antibody, for the treatment of autoimmune and inflammatory diseases. | |
 |

AnaptysBio (ANAB) has the following price history information. Looking back at ANAB historical stock prices for the last five trading days, on August 03, 2026, ANAB opened at $53.40, traded as high as $53.98 and as low as $51.85, and closed at $53.66. Trading volume was a total of 433.70K shares. On August 04, 2026, ANAB opened at $55.14, traded as high as $55.48 and as low as $53.41, and closed at $55.13. Trading volume was a total of 417.60K shares. On August 05, 2026, ANAB opened at $55.42, traded as high as $56.65 and as low as $54.33, and closed at $54.99. Trading volume was a total of 316.60K shares. On August 06, 2026, ANAB opened at $55.28, traded as high as $56.07 and as low as $53.45, and closed at $54.77. Trading volume was a total of 288.80K shares. On August 07, 2026, ANAB opened at $55.20, traded as high as $57.38 and as low as $55.13, and closed at $56.61. Trading volume was a total of 546.70K shares.
ANAB Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into AnaptysBio shares, starting with a $10,000 purchase of ANAB, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/27/2017 |
|
| End date: |
08/07/2026 |
|
| Start price/share: |
$11.69 |
|
| End price/share: |
$56.61 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
384.26% |
|
| Average Annual Total Return: |
18.00% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$48,411.32 |
|
| Years: |
9.53 |
|
|
 |
| Date |
Close |
| 08/03/2026 | $53.66 | | 08/04/2026 | $55.13 | | 08/05/2026 | $54.99 | | 08/06/2026 | $54.77 | | 08/07/2026 | $56.61 |
|
 |